EHRA Premium Access

Is it worth the money? Cost-effectiveness in electrophysiology

Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Policy initiative
Session type: Symposium
Date: 20 June 2017
Time: 14:00 - 15:30

Congress Session

4 presentations in this session

Comparative cost-effectiveness of atrial fibrillation ablation versus pharmacological therapy.

Speaker: Doctor J. Caldwell (Hull, GB)
Thumbnail

Patient compliance and outcomes of pharmacological therapy and atrial fibrillation ablation.

Speaker: Professor S. Saksena (Warren, US)
Thumbnail

Commissioning and reimbursement of atrial fibrillation ablation in Europe.

Speaker: Professor F. Braunschweig (Stockholm, SE)
Thumbnail

The role of the ESC Health Policy: relevance to electrophysiology and cardiac device practice.

Speaker: Professor P. Vardas (Heraklion, GR)
Thumbnail

4 speakers from this session

Doctor Jane Cochrane Caldwell

Hull and East Yorkshire Hospitals NHS Trust, Hull (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Professor Sanjeev Saksena

Electrophysiology Research Foundation, Warren (United States of America)
2 presentations
0 follower

Professor Frieder Braunschweig

Karolinska University Hospital, Stockholm (Sweden)
14 presentations
0 follower

Professor Panagiotis Vardas

University Hospital of Heraklion, Heraklion (Greece)
15 presentations
1 follower

This platform is supported by

logo Novo Nordisk